Addiction and mental health

In programme
13 sessions 53 presentations View the programme

About

This track is co-produced by the Society for the Study for Addiction. 

This track explores the intersection of addiction, mental health, and co-occurring disorders:

  • Addiction, mental health, and co-occurring mental illness in different populations.
  • Treatment strategies for co-occurring addiction and mental health disorders and the effectiveness of combined integrated treatment models.
  • Strategies for the prevention of mental health problems among people experiencing addiction.
  • Digital approaches to the treatment and prevention of co-occurring mental health and addiction problems.
  • Addiction and trauma.
  • Addiction and neurodiversity.
  • Impact of co-occurring mental health problems on drug-related harms.

Sessions

Wednesday, 23 October

10:50

Lives at risk: mental health and substance use

10:50 to 12:20
Auditorium VII
Oral presentation session
13:20

Neuroscience and cognition

13:20 to 14:50
Auditorium III
Short communication session

Tobacco, mental health and other substance use

13:20 to 14:50
Auditorium VII
Oral presentation session
15:00

Substance use and psychosis

15:00 to 16:30
Auditorium VII
Oral presentation session

Trauma and addiction - developing skills in the screening of traumatic experiences in addiction care

15:00 to 16:30
Room 1.10
Workshop
16:50

Understanding interrelationships: mental health and substance use

16:50 to 18:20
Auditorium VII
Oral presentation session

Thursday, 24 October

10:50

International collaboration to understand and address the co-occurrence of addiction with ADHD and autism spectrum disorders

10:50 to 12:20
Auditorium I
Major session
13:20

Young people, mental health and substance use

13:20 to 14:50
Auditorium VII
Oral presentation session
15:00

How can treatment be a better experience?

15:00 to 16:30
Auditorium VII
Oral presentation session
16:50

Substance use and mental health in treatment settings

16:50 to 18:20
Auditorium VII
Oral presentation session

Friday, 25 October

10:50

Trauma and substance use

10:50 to 12:20
Auditorium VII
Oral presentation session
13:20

Substance use and mental health in prison settings

13:20 to 14:50
Auditorium VII
Oral presentation session

Holistic care for mental well-being

13:20 to 14:50
Room 1.05
Short communication session

Presentations

Wednesday, 23 October

10:50
Oral presentation

The impact of severe mental illness on treatment retention and all-cause mortality of people in opioid agonist treatment

10:50 to 12:20
Auditorium VII
Nicola Jones
Oral presentation

Hazardous substance use and mental health among refugees in shared accommodations – a mixed-methods study

10:50 to 12:20
Auditorium VII
Miriam Lorenz
Oral presentation

Suicide-related service presentations following residential treatment for substance use disorders: a data linkage study

10:50 to 12:20
Auditorium VII
Calvert Tisdale
Oral presentation

Bipolar disorder and severe poisoning due to medicines or illicit substances

10:50 to 12:20
Auditorium VII
Aleksi Hamina
13:20
Oral presentation

Smokers’ careers and mental health: overlapping perspectives on cannabis and tobacco use

13:20 to 14:50
Auditorium VII
Joana Sisternas-Tusell
Short communication

Attention and reward related brain activity in cannabis users: A registered report of a longitudinal study

13:20 to 14:50
Auditorium III
Inês Macedo
Short communication

Neural Correlates of Addiction: A Resting-State Meta-Analysis of Substance Use Disorders and Behavioral Addictions

13:20 to 14:50
Auditorium III
Marc Ritter
Short communication

The bodily parallel: Bridging Gaps in Current Theories of Addiction and Interoception

13:20 to 14:50
Auditorium III
Mateo Leganes-Fonteneau
Short communication

Social Cognition in people with substance use disorders

13:20 to 14:50
Auditorium III
Sónia Rodrigues
Short communication

Does lisdexamfetamine maintenance help or hinder cognitive function in people with current methamphetamine dependence?

13:20 to 14:50
Auditorium III
Raimondo Bruno
Short communication

NK1 antagonism modulates negative emotional processing in abstinent opioid dependent individuals and healthy controls

13:20 to 14:50
Auditorium III
Lexi Hand
Short communication

Easy to reach, hard to research: cognitive function and substance use characteristics of people with severe drug use.

13:20 to 14:50
Auditorium III
Nina Auestad
Oral presentation

Psychological distress, tobacco smoking and alcohol use: a population survey in Great Britain

13:20 to 14:50
Auditorium VII
Erikas Simonavičius
Oral presentation

How Are African Countries Leveraging Health Communication For Tobacco Use Prevention With Young People: A Scoping Review

13:20 to 14:50
Auditorium VII
Charity Aienobe-Asekharen
Short communication

Cognitive impairment as a predictor of long-term psychological distress in patients with polysubstance use disorders

13:20 to 14:50
Auditorium III
Jens Hetland
Oral presentation

Levels of toxicants among people who vape, smoke, dual use, or do neither among people with and without psychosis.

13:20 to 14:50
Auditorium VII
Eve Taylor
15:00
Oral presentation

Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis

15:00 to 16:30
Auditorium VII
Antti Mustonen
Oral presentation

Antipsychotics and relapse risk in persons with first-episode psychosis and co-occurring cannabis use disorder

15:00 to 16:30
Auditorium VII
Heidi Taipale
Oral presentation

“Into a whirlwind”: Navigating psychosis and anti-psychotic treatment among youth entrenched in an urban drug scene

15:00 to 16:30
Auditorium VII
Trevor Goodyear
Oral presentation

Cannabinoid Use Experience among inpatients with psychotic symptoms – A Cross-Sectional study in a Portuguese Hospital

15:00 to 16:30
Auditorium VII
Carolina Afonso Romano
16:50
Oral presentation

The relationship between self-reported childhood maltreatment and mental health in substance use disorders

16:50 to 18:20
Auditorium VII
Aleksander Hagen Erga
Oral presentation

Effects of cannabis use timing and formulation on sleep among young adults who report high-intensity alcohol use

16:50 to 18:20
Auditorium VII
Elizabeth R. Aston
Oral presentation

Examining Associations Between Alcohol and Cannabis Simultaneous and Concurrent Co-Use and Mental Health Outcomes

16:50 to 18:20
Auditorium VII
Bradley Conner
Oral presentation

Comorbidity of substance use disorders and other mental health disorders: towards a common European approach

16:50 to 18:20
Auditorium VII
Marta Torrens

Thursday, 24 October

10:50
Keynote presentation

International Collaboration on ADHD and Substance Abuse (ICASA): Mission, studies, results, and plans

10:50 to 12:20
Auditorium I
Wim van der Brink
Keynote presentation

International Collaboration on ADHD and Substance Abuse: Consensus statements

10:50 to 12:20
Auditorium I
Cleo Crunelle
Keynote presentation

Identifying the most important research, policy and practice questions for substance use, problematic alcohol use and behavioural addictions in autism (SABA-A): A priority setting partnership

10:50 to 12:20
Auditorium I
Julia Sinclair
13:20
Oral presentation

Dynamic associations between anxiety and alcohol use from early adolescence to young adulthood.

13:20 to 14:50
Auditorium VII
Margot Peeters
Oral presentation

A randomized controlled trial of support programs for parents of treatment-refusing substance using young adults

13:20 to 14:50
Auditorium VII
Ola Siljeholm
Oral presentation

Understanding substance use and affective symptoms in late adolescents in an urban context: A network approach

13:20 to 14:50
Auditorium VII
Helle Larsen
Oral presentation

Substance use variation among LGBTQ+ youth: stress, resilience and ecosystemic intervention

13:20 to 14:50
Auditorium VII
Julie-Christine Cotton
15:00
Oral presentation

Functional recovery among patients with dual disorders: the role of stigma

15:00 to 16:30
Auditorium VII
Nusa Segrec
Oral presentation

Dropout from addiction treatment: predictors, patient profiles, outcomes, and recommendations to improve care.

15:00 to 16:30
Auditorium VII
Marie-Josee Fleury
Oral presentation

Service user and Carer perspective on Treatment for Co-Occurring Mental Health and Substance Use Problems (RECO Study)

15:00 to 16:30
Auditorium VII
Elizabeth Hughes
Oral presentation

The use of patient-reported outcomes in residential alcohol & drug services in Belgium: findings from the OMER-BE study

15:00 to 16:30
Auditorium VII
Amine Zerrouk
16:50
Oral presentation

Dual diagnosis and their care pathways for help-seeking: a multi-center study from India

16:50 to 18:20
Auditorium VII
Abhishek Ghosh
Oral presentation

Intervention development of a nature-based programme for co-occurring mental health and substance use problems.

16:50 to 18:20
Auditorium VII
Wendy Masterton
Oral presentation

Impact of mental health on retention in OAT

16:50 to 18:20
Auditorium VII
Lucy Thi Tran
Oral presentation

Islands in the stream: The accessibility of mental health care for persons with substance use problems in Belgium

16:50 to 18:20
Auditorium VII
Clara De Ruysscher

Friday, 25 October

10:50
Oral presentation

Qualitative examination of coping motives, microaggressions, and psychological distress among bisexual+ women survivors

10:50 to 12:20
Auditorium VII
Gabriela Lopez
Oral presentation

Posttraumatic stress disorder treatment in patients with co- substance use disorders: a randomized clinical trial

10:50 to 12:20
Auditorium VII
Marleen de Waal
Oral presentation

Implementing trauma-focused integrated treatment for women with PTSD and substance use disorder in Australia

10:50 to 12:20
Auditorium VII
Shalini Arunogiri
Oral presentation

The feasibility, meaningfulness, and preliminary effect of trauma focused treatment for drug use disorders in Denmark

10:50 to 12:20
Auditorium VII
Sidsel Karsberg
13:20
Short communication

Breaking Chains: Interventions for Reducing Internalized Stigma and Boosting Self-Esteem in Substance Use Behaviors

13:20 to 14:50
Room 1.05
Andreia Florido
Short communication

Addressing the needs of individuals with concurrent disorders: a complexity arising

13:20 to 14:50
Room 1.05
karine Gaudreault
Short communication

Towards a better connection

13:20 to 14:50
Room 1.05
Chico Taguba
Oral presentation

Radio theater-based prison artistic intervention: a mixed-method evaluation

13:20 to 14:50
Auditorium VII
Isabel Silva
Oral presentation

Interventions to reduce harms related to drug use among people who experience incarceration: A systematic review

13:20 to 14:50
Auditorium VII
Christel Macdonald
Oral presentation

PRS20: drug use and perceived mental health concerns among people living in prison in the Grand-Duchy of Luxembourg

13:20 to 14:50
Auditorium VII
Tom Kugener
Short communication

Mitigating Trauma and Problematic Drug Use with a Focus on Empathy – Insights from Metzineres

13:20 to 14:50
Room 1.05
Aura Roig Forteza
Short communication

Intervention variability predicts social rehabilitation indicators at discharge in long-term residential treatment.

13:20 to 14:50
Room 1.05
Katia Barreto
Short communication

Towards improved access for people with a migration background to harm reduction and health services.

13:20 to 14:50
Room 1.05
Ancella Voets
Short communication

Trauma-Informed care approach with people who use drugs

13:20 to 14:50
Room 1.05
Joana Pires
View all tracks